Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Immuron (IMRN) Net Margin (2016 - 2023)

Immuron's quarterly Net Margin came in at 88.01% in Q4 2023, down 40108.0% year-on-year from N/an in Q4 2022, and up 94.11% quarter-over-quarter from 1493.47% in Q2 2023.

Immuron has reported Net Margin for 8 years, with the latest figure at 88.01% in Q4 2023.

  • For the quarter ending Q4 2023, Net Margin fell 40108.0% year-over-year to 88.01%; the trailing twelve-month figure through Dec 2024 stood at 0.0% (up 5.0% YoY), and the FY2025 full-year result was 71.58%, up 6991.0% from the prior year.
  • Net Margin for Q4 2023 stood at 88.01%, up from 1493.47% in the prior quarter.
  • The five-year high for Net Margin was 313.07% in Q4 2022, with the low at 1493.47% in Q2 2023.
  • Average Net Margin over 5 years is 292.12%, with a median of 92.87% recorded in 2019.
  • Year-over-year, Net Margin surged 38659 bps in 2021 and plunged 40108 bps in 2023.
  • Tracing IMRN's Net Margin over 5 years: stood at 97.73% in 2019, then plunged by 296 bps to 386.59% in 2020, then jumped by 100 bps to 0.0% in 2021, then surged by 39917433 bps to 313.07% in 2022, then slumped by 128 bps to 88.01% in 2023.
  • The last three Net Margin figures came in at 88.01% (Q4 2023), 1493.47% (Q2 2023), and 313.07% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -88.01%
Jun 30, 2023 -1,493.47%
Dec 31, 2022 313.07%
Dec 31, 2021 0.00%
Dec 31, 2020 -386.59%
Dec 31, 2019 -97.73%
Dec 31, 2018 -161.71%
Dec 31, 2017 535.91%
Dec 31, 2016 482.10%
Jun 30, 2016 -379.89%